A small, preliminary study found that marathoners were much more likely to have precancerous growths. Experts aren’t sure why. A study of 100 marathon and ...

CT-P6 demonstrates strong efficacy and safety in HER2-positive advanced gastric cancer, achieving an 82% disease control rate in real-world settings. Data from a post-marketing surveillance study of ...

Share on Pinterest About three-quarters of gastric cancer cases worldwide have been linked to the common bacteria H. pylori. Courtney Hale/Getty Images The vast majority of stomach cancer cases have ...

1 Wujin Institute of Molecular Diagnostics and Precision Cancer Medicine of Jiangsu University, Wujin Hospital Affiliated With Jiangsu University, Changzhou, Jiangsu, China 2 Jiangsu Key Laboratory of ...

Adcentrx Therapeutics advances gastric cancer treatment with FDA orphan drug designation for ADRX-0405, a promising antibody-drug conjugate in clinical trials. The FDA has granted orphan drug ...

Globally, stomach cancer is on the rise in young people, but new research shows that three-quarters of future cases could be prevented by screening for and treating a common bacterial infection: ...

First-line treatment with bemarituzumab plus chemotherapy (mFOLFOX6) demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS) vs placebo plus ...

1. Event-free survival at 24 months was 67.4% in the durvalumab group and 58.5% in the placebo group, with HR 0.71 (significant). 2. Adverse events grade 3-4 occurred in 71.6% in the durvalumab group ...

Abstract: Gastric cancer is a major global health issue characterized by high incidence and mortality rates. Early gastric cancer has a more favorable prognosis, yet most patients are diagnosed at an ...

Gastric cancer, a prevalent malignancy globally, is influenced by various factors. The imbalance in the gut microbiome and the existence of particular intratumoural microbiota could have a strong ...